Patents by Inventor Unchalee Kositprapa

Unchalee Kositprapa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE
    Publication number: 20150072001
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: March 10, 2014
    Publication date: March 12, 2015
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 8668931
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: March 11, 2014
    Assignee: Actavis, Inc.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE
    Publication number: 20130266647
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: May 8, 2013
    Publication date: October 10, 2013
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Rapidly disintegrating antihistamine formulation
    Patent number: 8529946
    Abstract: The invention relates to a rapidly disintegrating oral antihistamine dosage formulation and method of preparing the rapidly disintegrating formulation wherein the formulation is designed to dissolve in the buccal cavity of the patient.
    Type: Grant
    Filed: September 28, 2004
    Date of Patent: September 10, 2013
    Assignee: Andrx Pharmaceuticals, LLC
    Inventors: Unchalee Kositprapa, Nilobon Podhipleux, Avinash Nangia, Samuel Yuk
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 8470368
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: June 2, 2011
    Date of Patent: June 25, 2013
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 8309125
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: July 14, 2010
    Date of Patent: November 13, 2012
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Unchalee Kositprapa, Avinash Nangia, John Cardinal, Robert I. Goldfarb
  • Antihistamine and decongestant system
    Patent number: 8092831
    Abstract: The present invention relates to an oral pharmaceutical formulation that employs: (1) a compressed core containing a decongestant or pharmaceutically acceptable salt thereof; (2) a delayed release coating on the compressed core and (3) immediate release therapeutic amounts of a decongestant and an antihistamine.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: January 10, 2012
    Assignee: Andrx Pharmaceuticals, LLC
    Inventors: Unchalee Kositprapa, Mongkol Sriwongjanya
  • NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE
    Publication number: 20110262538
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: June 2, 2011
    Publication date: October 27, 2011
    Applicant: WATSON PHARMACEUTICALS, INC.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 7959946
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: June 14, 2011
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Novel Pharmaceutical Formulation Containing A Biguanide and a Thiazolidinedione Derivative
    Publication number: 20100316708
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: July 14, 2010
    Publication date: December 16, 2010
    Inventors: Unchalee Kositprapa, Avinash Nangia, John Cardinal, Robert I. Goldfarb
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 7785627
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: August 31, 2010
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John Cardinal, Avinash Nangia
  • Once a day antihistamine and decongestant formulation
    Patent number: 6994871
    Abstract: A controlled release pharmaceutical formulation for the administration of an antihistamine and decongestant to a patient wherein the formulation employs a compressed matrix core for the controlled release of a decongestant and an immediate release coating for the immediate release of the antihistamine.
    Type: Grant
    Filed: September 16, 2002
    Date of Patent: February 7, 2006
    Assignee: Andrx Pharmaceuticals, Inc.
    Inventors: Mongkol Sriwongjanya, Timothy Weng, David Barman, Unchalee Kositprapa
  • Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
    Patent number: 6869615
    Abstract: An oral solid dosage form includes a therapeutically effective amount of an NSAID and a proton pump inhibitor in an amount effective to inhibit or prevent gastrointestinal side effects normally associated with the NSAID. Also disclosed is a method of treating a human patient in need of antiinflammatory, analgesic and/or antipyretic therapy, comprising orally administering to the patient an oral pharmaceutical dosage form which includes a therapeutically effective amount of an NSAID and an amount of a proton pump inhibitor effective to substantially inhibit gastrointestinal side effects of the NSAID. The invention is further related to a method of prophylactically treating a human patient who is on a therapy known to have significant gastrointestinal side effects or is about to begin such a therapy, via concurrent administration of an NSAID and a proton pump inhibitor in a combination (single) oral dosage form.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: March 22, 2005
    Assignee: Andrx Labs LLC
    Inventors: Chih-Ming Chen, Unchalee Kositprapa
  • Rapidly disintegrating antihistamine formulation
    Publication number: 20050042286
    Abstract: The invention relates to a rapidly disintegrating oral antihistamine dosage formulation and method of preparing the rapidly disintegrating formulation wherein the formulation is designed to dissolve in the buccal cavity of the patient.
    Type: Application
    Filed: September 28, 2004
    Publication date: February 24, 2005
    Inventors: Unchalee Kositprapa, Nilobon Podhipleux, Avinash Nangia, Samuel Yuk
  • Omeprazole formulation
    Patent number: 6855336
    Abstract: A stable pharmaceutical composition of omeprazole for oral administration which consists essentially of: (a) a core of Omeprazole or a pharmaceutically equivalent salt, a filler and an alkaline material selected from the group consisting of lysing and arginine; and (b) a single layer of coating on said core which comprises a layer of an enteric coating agent which is applied from an organic solvent based system.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: February 15, 2005
    Assignee: ANDRX Pharmaceuticals, Inc.
    Inventors: Chih-Ming Chen, Joseph Chou, Unchalee Kositprapa
  • Omeprazole formulation
    Publication number: 20040175427
    Abstract: A stable pharmaceutical composition of omeprazole for oral administration which consists essentially of: (a) a core of Omeprazole or a pharmaceutically equivalent salt, a filler and an alkaline material selected from the group consisting of lysing and arginine; and (b) a single layer of coating on said core which comprises a layer of an enteric coating agent which is applied from an organic solvent based system.
    Type: Application
    Filed: March 19, 2004
    Publication date: September 9, 2004
    Inventors: Chih-Ming Chen, Joseph Chou, Unchalee Kositprapa
  • Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
    Publication number: 20040166162
    Abstract: The subject invention is multi layer pharmaceutical dosage form comprising at least two layers whereby a proton pump inhibitor is in one distinct layer and an aluminum, magnesium or calcium antacid salt is in a second distinct layer.
    Type: Application
    Filed: January 21, 2004
    Publication date: August 26, 2004
    Inventors: Robert Niecestro, Unchalee Kositprapa, Yoon Oh, Avinash Nangia, John R. Cardinal, Elliot F. Hahn
  • Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Publication number: 20040161462
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: February 12, 2004
    Publication date: August 19, 2004
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
    Publication number: 20040131672
    Abstract: The present invention relates to a directly compressible pharmaceutical composition that contains greater than 15 weight percent of a poorly flowing drug powder, greater than 2 weight percent of a super disintegrant and greater the 1 weight percent of a glidant.
    Type: Application
    Filed: January 7, 2003
    Publication date: July 8, 2004
    Inventors: Nilobon Podhipleux, Unchalee Kositprapa, Avinash Nangia
  • Omeprazole formulation
    Publication number: 20040131684
    Abstract: A stable pharmaceutical composition of omeprazole for oral administration which consists essentially of: (a) a core of Omeprazole or a pharmaceutically equivalent salt, a filler and an alkaline material selected from the group consisting of lysing and arginine; and (b) a single layer of coating on said core which comprises a layer of an enteric coating agent which is applied from an organic solvent based system.
    Type: Application
    Filed: November 13, 2003
    Publication date: July 8, 2004
    Inventors: Chih-Ming Chen, Joseph Chou, Unchalee Kositprapa